Literature DB >> 22594009

[Central neuropsychiatric involvement in systemic lupus erythematosus].

S Madrane1, C Ribi.   

Abstract

About one third of patients with systemic lupus erythematosus (SLE) will present neurological or psychiatric symptoms in the course of the disease. Before attributing neuro-psychiatric illness to SLE, other causes have to be excluded, such as infections and treatment-related toxicity. Some manifestations of neuropsychiatric SLE (NPSLE) reflect active systemic disease, while other arise from chronic damage and may occur during apparent remission. Many clinical pictures are associated with antibodies, such as those targeting phospholipids, N-methyl-D-aspartate-receptor and anti-ribosomal P protein. This review discusses clinical manifestations and pathogenesis of central NPSLE, with a focus on the principal antibodies associated and other diagnostic tools at hand.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22594009

Source DB:  PubMed          Journal:  Rev Med Suisse        ISSN: 1660-9379


  1 in total

1.  The association among antioxidant enzymes, autoantibodies, and disease severity score in systemic lupus erythematosus: comparison of neuropsychiatric and nonneuropsychiatric groups.

Authors:  Yu-Jih Su; Tien-Tsai Cheng; Chung-Jen Chen; Wen-Chan Chiu; Wen-Neng Chang; Nai-Wen Tsai; Chia-Te Kung; Wei-Che Lin; Chih-Cheng Huang; Ya-Ting Chang; Chih-Min Su; Yi-Fang Chiang; Ben-Chung Cheng; Cheng-Hsien Lu
Journal:  Biomed Res Int       Date:  2014-04-27       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.